Cite
HARVARD Citation
Carrillo Palau, M. et al. (n.d.). P437 Early therapeutic drug monitoring of Adalimumab, but not HLADQ*A1 determination, predicts inflammatory bowel disease outcome. Journal of Crohn's and colitis. p. i566. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carrillo Palau, M. et al. (n.d.). P437 Early therapeutic drug monitoring of Adalimumab, but not HLADQ*A1 determination, predicts inflammatory bowel disease outcome. Journal of Crohn's and colitis. p. i566. [Online].